Business & Industry
- Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
- Sanofi Foundation opens new chapter centered on future generations
- Bristol Myers Squibb evolves and expands Standing in the Gaap to advance more equitable care in multiple myeloma
- Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform
- Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Research & Development
- New approach to the development of non-opioid painkillers
- More than half of U.S. adults now eligible for statins under new guidelines
- Many countries overusing powerful antibiotics
- GLP-1 diabetes drugs linked to increased risk of hair loss
- Study reveals structure of brain protein and identifies potential drug target for epilepsy research
- A secret weapon against superbugs
- Researchers clear two major hurdles for minimally invasive cancer therapy
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA expands artificial intelligence capabilities with agentic AI deployment
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis